Relates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias
REFERRED TO INSURANCE
Email me when S 9523 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 9523. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill amends New York’s insurance statutes to require that any medical, major medical, or similar comprehensive policy—whether individual, group, or issued by certain health corporations—cover all medically necessary diagnostic tests and FDA‑approved drugs that aim to slow Alzheimer’s disease and related dementias. Coverage cannot be limited by step‑therapy requirements. The changes take effect on January 1 of the year after the law is enacted and apply to policies issued or renewed thereafter.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 9523
3 free questions a day, no accountHistory
- REFERRED TO INSURANCE
Sponsors
- Cordell Cleare · sponsor
- James Skoufis
- Joseph P. Addabbo Jr.
- Kevin S. Parker
- Kristen Gonzalez
- Pete Harckham
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 9523 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 9523 freeOr ask your AI assistant about S 9523 directly:
Add to Claude, ChatGPT or Cursor